Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.

Abstract

Doxorubicin (DOX) is an anthracycline antibiotic commonly employed for the treatment of various cancers. However, its therapeutic uses are hampered by side effects associated with cumulative doses during the course of treatment. Whereas deregulation of autophagy in the myocardium has been involved in a variety of cardiovascular diseases, the role of autophagy in DOX-induced cardiomyopathy remains debated. Our earlier studies have shown that DOX treatment in a rat animal model leads to increased expression of the novel stress-inducible protein insulin-like growth factor II receptor-α (IGF-IIRα) in cardiac tissues, which exacerbated the cardiac injury by enhancing oxidative stress and p53-mediated mitochondria-dependent cardiac apoptosis. Through this study, we investigated the contribution of IGF-IIRα to dysregulation of autophagy in heart using both in vitro H9c2 cells (DOX treated, 1 µM) and in vivo transgenic rat models (DOX treated, 5 mg/kg ip for 6 wk) overexpressing IGF-IIRα specifically in the heart. We found that IGF-IIRα primarily localized to mitochondria, causing increased mitochondrial oxidative stress that was severely aggravated by DOX treatment. This was accompanied by a significant perturbation in mitochondrial membrane potential and increased leakage of cytochrome c, causing increased cleaved caspase-3 activity. There were significant alterations in phosphorylated AMP-activated protein kinase (p-AMPK), phosphorylated Unc-51 like kinase-1 (p-ULK1), PARKIN, PTEN-induced kinase 1 (PINK1), microtubule-associated protein 1 light chain 3 (LC3), and p62 proteins, which were more severely disrupted under the combined effect of IGF-IIRα overexpression plus DOX. Finally, LysoTracker Red staining showed that IGF-IIRα overexpression causes lysosomal impairment, which was rescued by rapamycin treatment. Taken together, we found that IGF-IIRα leads to mitochondrial oxidative stress, decreased antioxidant levels, disrupted mitochondrial membrane potential, and perturbed mitochondrial autophagy contributing to DOX-induced cardiomyopathy.

• Authors: Sudhir Pandey, Wei-Wen Kuo, Chia-Yao Shen, Yu-Lan Yeh, Tsung-Jung Ho, Ray-Jade Chen, Ruey-Lin Chang, Pei-Ying Pai, Vijaya Padma Viswanadha, Chih-Yang Huang, Chih-Yang Huang
• Journal: American journal of physiology. Cell physiology (Am J Physiol Cell Physiol) Vol. 317 Issue 2 Pg. C235-C243 (08 01 2019) ISSN: 1522-1563 [Electronic] United States
• PMID: 31116582 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibiotics, Antineoplastic
• Apoptosis Regulatory Proteins
• Autophagy-Related Proteins
• Receptor, IGF Type 2
• Doxorubicin

Topics

• Animals
• Antibiotics, Antineoplastic (toxicity)
• Apoptosis Regulatory Proteins (metabolism)
• Autophagy-Related Proteins (metabolism)
• Cardiotoxicity
• Cell Line
• Doxorubicin (toxicity)
• Heart Diseases (chemically induced, genetics, metabolism, pathology)
• Lysosomes (drug effects, metabolism, pathology)
• Membrane Potential, Mitochondrial (drug effects)
• Mitochondria, Heart (drug effects, metabolism, pathology)
• Mitophagy (drug effects)
• Myocytes, Cardiac (drug effects, metabolism, pathology)
• Oxidative Stress (drug effects)
• Rats, Sprague-Dawley
• Rats, Transgenic
• Receptor, IGF Type 2 (genetics, metabolism)
• Signal Transduction (drug effects)